ESR1 and breast cancer: In the context of estrogen receptor (ER)-positive BC, IFI16 plays a pivotal role in augmenting tumor growth by facilitating the transcriptional activation of aromatase and subsequent E2 production in adipose tissue (Figure 4, right panels and Table 2) (139).